Spindle cell neoplasm harboring MAPK signaling pathway gene translocation from the spectrum of <i>NTRK</i>-rearranged spindle cell tumor-Reference-Cited by-同舟云学术

Spindle cell neoplasm harboring MAPK signaling pathway gene translocation from the spectrum of <i>NTRK</i>-rearranged spindle cell tumor

Published:2022-12-26 Issue:4 Volume:21 Page:152-157
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Tarakanova A. V.¹^ORCID,Sharlay A. S.¹^ORCID,Panferova A. V.¹^ORCID,Sidorov I. V.¹^ORCID,Konovalov D. M.¹^ORCID

Affiliation:

1. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Publisher

Fund Doctors, Innovations, Science for Children

Subject

Oncology,Hematology,Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Reference18 articles.

1. Davis J.L., Lockwood С.М., Stohr В., Boecking С., Al-Ibraheemi А., DuBois S.G., et al. Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors. Am J Surg Pathol 2019; 43 (4): 435–45. DOI:10.1097/PAS.0000000000001203

2. Davis J.L., Al-Ibraheemi A., Rudzinski E.R., Surrey L.F. Mesenchymal neoplasms with NTRK and other kinase gene alterations. Histopathology 2022; 80 (1): 4–18. DOI:10.1111/his.14443

3. Antonescu C.R. Emerging soft tissue tumors with kinase fusions: An overview of the recent literature with an emphasis on diagnostic criteria. Genes Chromosomes Cancer 2020; 59 (8): 437–44. DOI:10.1002/gcc.22846

4. Suurmeijer A.J.H., Dickson B.C., Swanson D., Zhang L., Sung Y.S., Cotzia P., et al. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosomes Cancer 2018; 57: 611–21. DOI:10.1002/gcc.22671

5. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020.